VOA examines global polio eradication efforts

NewsGuard 100/100 Score

VOA News reports on global efforts to eradicate polio, writing, "Experts say with India now polio-free and the total number of cases at the lowest level ever, this is an opportunity to change history and eradicate the disease entirely." "The oral polio vaccine has cut the number of polio cases worldwide by 99 percent since 1988," but, "[f]or the past 10 years, ... eliminating that last percent has remained a challenge," the news service continues. "The three countries where polio is still endemic -- Nigeria, Pakistan, and Afghanistan -- are conducting aggressive immunization campaigns to vaccinate more children against the disease," VOA notes.

"While polio eradication is urgent, [Ellyn Ogden, worldwide polio eradication coordinator for USAID,] said these last remaining reservoirs, such as Nigeria and Pakistan, make it difficult to put a date on success," VOA writes. Liam Donaldson, chair of the Independent Monitoring Board for the Global Polio Eradication Initiative, "said polio eradication programs are not on track to stop polio virus transmission by 2012" (Sinha, 9/3).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Nigeria first to rollout new Men5CV vaccine against meningitis